Articles by: Alison Garobi

Novartis Unveils New Analysis Supporting Long-Term Efficacy of Gilenya in MS Patients

Novartis Unveils New Analysis Supporting Long-Term Efficacy of Gilenya in MS Patients

ADRs of Novartis (NVS) were marginally higher pre-market Thursday after the Swiss drugmaker announced a new analysis from Phase III clinical trials that reinforce the long-term efficacy profile of Gilenya for treating patients with relapsing multiple sclerosis. The analysis evaluated the number of Gilenya patients with relapsing multiple sclerosis who […]

October 8, 2015 ·
Canadian Solar, ReneSola To Withdraw from EU Trade Deal

Canadian Solar, ReneSola To Withdraw from EU Trade Deal

Shares of solar panel companies Canadian Solar (CSIQ) and ReneSola (SOL) rose in Friday’s afternoon trade after both companies said they will exit the European Commission’s minimum import price (MIP) agreement. CSIQ shares are up 5.3% at $33.17, with a 52-week range of $18.68 – $41.12; RSOL shares are up […]

June 6, 2015 ·